NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Kerecis, the Medical-Fish-Skin Company, Named One of Europe’s Fastest Growing Companies by Financial Times

REYKJAVIK, Iceland & ARLINGTON, Va.--(BUSINESS WIRE)--Kerecis® has been included in the FT1000 list of Europe’s fastest growing companies. The medical-fish-skin company ranked fifth in the healthcare and life sciences category–and 246th overall–in the seventh annual list compiled by the “Financial Times.” This is the first time that Kerecis has been included in the prestigious list.

GFSArlington_3

Facilities

NS B2B

Bezos Earth Fund Invests $34 Million....
21 Mar 23

BioNTech enters mRNA research partnership with....
07 Oct 22

Novo Nordisk teams up with Microsoft....
13 Sep 22

WuXi STA opens new oligonucleotide and....
07 Jul 22

DEALS

Sanofi to acquire Provention Bio for $2.9bn. (Credit: Barbara from Pixabay)

Sanofi agrees to acquire Provention Bio....
14 Mar 23

Dr. Reddy’s to buy Mayne Pharma’s....
28 Feb 23

Pfizer in early-stage talks to acquire....
28 Feb 23

CVS Health to acquire US healthcare....
09 Feb 23

CONTRACTS

Janssen Biotech licenses RenLite platform. (Credit: Michal Jarmoluk from Pixabay)

Janssen Biotech in-licenses RenLite platform from....
09 Mar 23

Volastra in-licenses Amgen’s sovilnesib; secures $60m....
08 Mar 23

FDB agrees to manufacture Argenx’s antibody....
28 Oct 22

AstraZeneca, Gatehouse Bio extend partnership to....
09 Sep 22

Company Insight